BioAge Share Price

BioAge Share Price

NASDAQ: BIOA | Micro Cap | Healthcare
$4.28
-$0.43 (-9.13%) Last updated on 21 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

BioAge Stock Performance

Open
$4.60
Prev. Close
$4.71
Circuit Range
N/A
Day Range
$4.25 - $4.79
Year Range
$4.25 - $25.88
Volume
43,075
Average Traded
$4.45

BioAge Share Price Today

As of 21 November 2026, BioAge Labs, Inc.'s share price is $4.28. The stock opened at $4.60, compared to its previous close of $4.71. During today's trading session, BioAge Labs, Inc.'s share price traded between $4.25 and $4.79, with an average price of $4.52. Over the past 52 weeks, the stock has recorded a high of $25.88 and a low of $4.25. In terms of performance, BioAge Labs, Inc.'s share price has declined by 75.21% over the last six months and is down 54.61% on a year-on-year basis.

BioAge Share Price Chart

Line chart of the BioAge price trend over the selected period. The price fell overall, ranging from 4.24 to 4.79, ending at 4.28.
$4.25$4.79
L
Show Current Price
H

BioAge Stock Fundamentals & Key Indicators

Market Cap
$153.79M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-2.35
Revenue (TTM)
$9.00B
Return On Equity (TTM)
-31.12%
Profit Margin
-895.67%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-29.14%

BioAge Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$3.08$2.77$2.45$0.30
Net Profit-$25.94-$22.25-$26.10-$33.50
Net Profit Margin-842.21%-803.25%-1065.31%-11166.67%
Income ChangeN/A14.23%-17.30%-28.35%

BioAge Annual Profit & Loss

All figures in USD

Particulars20242025
Revenue$0.00$9.00
Net Profit-$71.11-$80.61
Net Profit MarginN/A-895.67%
Income ChangeN/A-13.36%

BioAge Balance Sheet

All figures in USD Million

Particulars20252024
Non Current Assets8.11.13
Current Assets286.79357.1
Total Assets294.89358.23
Non Current Liabilities2.77.33
Current Liabilities20.1427.78
Total Liabilities22.8435.11
Shareholders' Equity272.05323.13

BioAge Cash Flow

Annually

All figures in USD Million

Particulars20252024
Operating-81.63-51.52
Investing-95.22-0.37
Financing11.47381.2

About BioAge

Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging. The company's technology platform and differentiated human datasets enable the identification of targets based on insights into molecular changes that drive aging. The Company operates and manages its business as one reportable and operating segment, which is the business of extending healthy human life by targeting molecular causes of aging.

BioAge Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$5.93
$4.28
-27.60%
Oct 2026
$7.06
$5.91
-16.65%
Sep 2026
$9.38
$7.08
-29.71%
Aug 2026
$9.61
$10.08
+11.50%
Jul 2026
$24.30
$9.04
-63.10%
Jun 2026
$17.16
$24.50
+41.91%
May 2026
$16.63
$17.27
+2.83%
Apr 2026
$17.91
$16.79
-4.03%
Mar 2026
$20.10
$17.50
-21.34%
Feb 2026
$19.73
$22.24
+16.90%
Jan 2026
$12.70
$19.02
+43.97%
Dec 2025
$9.14
$13.21
+40.14%

BioAge Share Price FAQs